|1.||Leslie, Ken E: 1 article (04/2006)|
|2.||Lepp, Dion: 1 article (04/2006)|
|3.||Pacan, Jennifer: 1 article (04/2006)|
|4.||Sabour, Parviz: 1 article (04/2006)|
|5.||Dingwell, Randy T: 1 article (04/2006)|
12/01/1987 - "Efficacy of multiple and single intramammary infusions of benzathine cloxacillin (500 mg/quarter) were compared for treatment of mastitis during the dry period. "
11/01/1974 - "Clinical efficacy of benzathine cloxacillin in dry-cow mastitis treatment."
09/01/1980 - "Benzathine cloxacillin as a dry-cow mastitis product."
10/18/1975 - "Farmers participating in the full mastitis control group agreed to treat each cow at drying off with 500 mg benzathine cloxacillin in each quarter, to have their milking machines tested and to correct any faults, and to practise teat dipping. "
03/01/1990 - "The efficacy of an ophthalmic ointment containing benzathine cloxacillin for treatment of infectious bovine keratoconjunctivitis was determined in 2 experiments. "
07/01/1989 - "A field study was performed to determine the effectiveness of benzathine cloxacillin for the treatment of infectious bovine keratoconjunctivitis in cattle from 2 farms located in northern California. "
03/01/1990 - "Topically applied benzathine cloxacillin for treatment of experimentally induced infectious bovine keratoconjunctivitis."
07/01/1989 - "Effectiveness of two benzathine cloxacillin formulations for treatment of naturally occurring infectious bovine keratoconjunctivitis."
12/24/1983 - "Single topical treatment for bovine keratoconjunctivitis using benzathine cloxacillin."
04/01/2006 - "Significantly more (P = 0.02) of the infections treated with tilmicosin (74%) than of those treated with benzathine cloxacillin (53%) were cured, and significantly more (P = 0.05) of the infections by group D (81%) than of those by group A (57%) or group F (54%) were cured. "
04/01/2006 - "The 1st database contained bacteriologic and cow data from a field study evaluating the efficacy in such infections of a new intramammary dry-cow therapy (DCT) containing tilmicosin phosphate, in comparison with a commercially available DCT containing benzathine cloxacillin. "
|4.||Body Weight (Weight, Body)